Vector image of black body surrounded by white clouds
Multiple Possible Causes of Long COVID Come into Focus
Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  
Multiple Possible Causes of Long COVID Come into Focus
Multiple Possible Causes of Long COVID Come into Focus

Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  

Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  

COVID-19
Lauren Gardner, this year's Lasker-Bloomberg Public Service Award winner, in front of the COVID-19 dashboard she helped create.
2022 Lasker Award Winners Announced
Katherine Irving | Sep 28, 2022
This year’s awards recognize work on integrins, noninvasive prenatal screening, and COVID-19 data tracking.
A surgical mask next to an open pill bottle that’s toppled over, spilling out red capsules meant to represent vitamin D supplements.
Vitamin D Likely Doesn’t Prevent COVID-19, Studies Find
Dan Robitzski | Sep 9, 2022
The results from two large clinical trials don't support the idea that supplements of the vitamin bolster immune defenses against SARS-CoV-2.
Exploring the SARS-CoV-2 Outer Cell Surface
Exploring the SARS-CoV-2 Outer Cell Surface: Lessons in Innate and Adaptive Immunity
The Scientist Creative Services Team
In this webinar, Alberto Lopez-Munoz will discuss SARS-CoV-2 nucleocapsid protein cell surface expression and its role in host immunity.
the Melbourne skyline with lake in foreground
New Australian Center Will Develop Therapies for Future Pandemics
Shawna Williams | Aug 31, 2022
Launched with a $172 million philanthropic donation and funds from the state of Victoria, the Melbourne-based research institute aims to construct drug discovery platforms to speed the introduction of new therapies.
Small vaccine bottles on a conveyer belt
Pfizer and Moderna COVID-19 Omicron Boosters Get OK from the FDA
Catherine Offord | Aug 31, 2022
The immunizations are designed to target the latest Omicron subvariants, and are only authorized for people who have already received their primary vaccinations.
Small Changes, Big Consequences
Small Changes, Big Consequences
Niki Spahich, PhD
To understand the mechanisms behind severe COVID-19, researchers identified common COVID-19 genetic risk variants that affect immune cell function.
Illustration of several warped and stretched analog clocks swirling around a central point.
It’s Not Just You: Lockdowns Had Us Living in “Blursday,” Study Says
Dan Robitzski | Aug 26, 2022
The Scientist spoke with Maximilien Chaumon about his database showing how COVID-19 related lockdowns warped more 2,800 people’s perception of time.
Anthony Fauci
Anthony Fauci Announces Departure from NIAID, Advisory Roles
Catherine Offord | Aug 22, 2022
The 81-year-old director says that he will step back from his positions this December, but that he will continue working to advance science and public health.
GENETIC PREDISPOSITION TO VITAMIN D DEFICIENCY CONTRIBUTES TO SEVERE COVID-19
Genetic Predisposition to Vitamin D Deficiency Contributes to Severe COVID-19
Iris Kulbatski, PhD
Ana Teresa Freitas discusses how individual variation in vitamin D synthesis and metabolism influences susceptibility to upper respiratory viruses.
An illustration of a pregnant women wearing a mask, surrounded by microbes
How COVID-19 Affects Pregnancy
Amanda Heidt | Aug 16, 2022
Evidence thus far shows that pregnant people infected with SARS-CoV-2 are at higher risk for severe disease and death, as well as complications in their pregnancies.
A translucent illustration of the BA.2.75 subvariant of SARS-CoV-2 against a black background
Experts Mixed on Risk of “Centaurus” Omicron Subvariant
Dan Robitzski | Aug 15, 2022
BA.2.75 is spreading rampantly in India and has so far reached at least 20 other countries, but it doesn’t seem to be outcompeting other Omicron SARS-CoV-2 subvariants.
A New Multiplexed SARS-CoV-2 Serological Assay Using Advanced Flow Cytometry
A New Multiplexed SARS-CoV-2 Serological Assay Using Advanced Flow Cytometry
The Scientist Creative Services Team
Julie Lovchik will discuss how advanced flow cytometry instrumentation facilitates multiplex assessment of IgG, IgM, and IgA antibodies against SARS-CoV-2.
Four glass vials sit on a reflective tabletop next to a syringe. Each is labeled as a subsequent dose in a four-dose series of COVID-19 vaccines.
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines
Dan Robitzski | Aug 11, 2022
Studies show that a fourth mRNA vaccine dose offers the elderly and other high-risk groups strong protection against hospitalization and death from COVID-19, but experts say benefits for other populations may be more limited.
Man in lab coat looking at the camera and smiling
Can Taking a Test Now Tell You if You’ve Already Had COVID-19?
Natalia Mesa | Aug 8, 2022
The Scientist asks Brigham and Women’s Hospital infectious disease specialist Lindsey Baden about testing for prior infections.
COVID-19 vaccine vials
COVID-19 Vaccines Induce Better Long-Term Immunity than Infection
Jennifer Zieba, PhD
For the first time, researchers performed a head-to head longitudinal study comparing the immune response elicited by mRNA and traditional COVID-19 vaccines to primary infections.
EXCLUSIVE
Colorful pills and capsules on a calendar background
Clinical Trial Registry Errors Undermine Transparency
Catherine Offord | Aug 2, 2022
A lack of comprehension among some researchers about how to use ClinicalTrials.gov may be hindering public access to trial information and holding up drug study results, an investigation by The Scientist finds.
metallic-looking illustration of coronavirus structure
How the Omicron Subvariant BA.5 Became a Master of Disguise—and What It Means for the Current COVID-19 Surge
Suresh V. Kuchipudi, The Conversation | Jul 26, 2022
Several mechanisms contribute to the increased transmissibility of this SARS-CoV-2 variant.
Long COVID: The Knowns and Unknowns
Long COVID: The Knowns and Unknowns
The Scientist Creative Services Team
Manali Mukherjee and Grace Lam discuss the presentation and implications of chronic, long-term COVID-19 infections.
Fluorescent cells in culture connected by tunneling nanotubules
SARS-CoV-2 Could Use Nanotubes to Infect the Brain
Natalia Mesa | Jul 21, 2022
Stressed cells can form hollow actin bridges to neighbors to get help, but the virus may hijack these tiny tunnels for its own purposes, a study suggests.